IRIS
PISCAZZI, ANNAMARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.165
EU - Europa 2.418
AS - Asia 1.864
SA - Sud America 280
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 7.744
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.119
CN - Cina 838
IE - Irlanda 722
SG - Singapore 586
UA - Ucraina 528
SE - Svezia 271
RU - Federazione Russa 223
BR - Brasile 215
IT - Italia 168
DE - Germania 143
HK - Hong Kong 134
TR - Turchia 111
FR - Francia 109
FI - Finlandia 104
VN - Vietnam 88
GB - Regno Unito 66
IN - India 41
BE - Belgio 30
CA - Canada 28
AR - Argentina 25
BD - Bangladesh 20
CZ - Repubblica Ceca 12
CO - Colombia 11
MX - Messico 10
NL - Olanda 9
EC - Ecuador 8
IQ - Iraq 8
PL - Polonia 7
ID - Indonesia 6
VE - Venezuela 6
AT - Austria 5
CL - Cile 5
JO - Giordania 5
JP - Giappone 5
LT - Lituania 5
AL - Albania 4
CR - Costa Rica 4
ES - Italia 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
AU - Australia 3
EU - Europa 3
IR - Iran 3
PE - Perù 3
PY - Paraguay 3
RO - Romania 3
BO - Bolivia 2
KW - Kuwait 2
MA - Marocco 2
MY - Malesia 2
NP - Nepal 2
PK - Pakistan 2
UY - Uruguay 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AZ - Azerbaigian 1
BY - Bielorussia 1
BZ - Belize 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
MW - Malawi 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
Totale 7.744
Salva come PNG Salva come JPEG
Città #
Dublin 722
Chandler 491
Jacksonville 373
Singapore 282
Dearborn 256
Ashburn 199
Nanjing 192
Nyköping 186
Beijing 148
New York 141
Hong Kong 134
Santa Clara 97
Dallas 92
Munich 80
Princeton 80
Wilmington 75
Nanchang 73
San Mateo 69
The Dalles 57
Ann Arbor 49
Moscow 46
Boardman 42
Shenyang 41
Des Moines 37
Tianjin 35
Hebei 33
Ho Chi Minh City 33
Los Angeles 33
Woodbridge 33
Brussels 30
Jiaxing 30
Kunming 30
Helsinki 27
Foggia 26
Changsha 19
São Paulo 18
Jinan 17
Council Bluffs 16
Hangzhou 16
London 16
Washington 14
Ningbo 13
Turku 13
Zhengzhou 13
Hanoi 12
Brno 10
Guangzhou 10
Lanzhou 10
Norwalk 10
San Francisco 10
Seattle 10
Taizhou 10
Toronto 10
Falls Church 9
Hilden 9
San Jose 9
Shanghai 9
Frankfurt am Main 8
Montreal 7
Nuremberg 7
Rio de Janeiro 7
Auburn Hills 6
Bari 6
Belo Horizonte 6
Changchun 6
Chicago 6
Fuzhou 6
Redwood City 6
Amman 5
Atlanta 5
Boston 5
Brasília 5
Chieti 5
Rome 5
Thái Nguyên 5
Ankara 4
Assago 4
Brooklyn 4
Can Tho 4
Dhaka 4
Falkenstein 4
Istanbul 4
Jakarta 4
Milan 4
Potenza 4
Quito 4
Bauru 3
Bogotá 3
Columbus 3
Curitiba 3
Da Nang 3
Haiphong 3
Hefei 3
Indaiatuba 3
Lajeado 3
Manfredonia 3
Milwaukee 3
Orange 3
Ottawa 3
Palombara Sabina 3
Totale 4.747
Salva come PNG Salva come JPEG
Nome #
GLI INIBITORI DELLA TRASCRITTASI INVERSA (RT) DOWN-REGOLANO LA PROLIFERAZIONE CELLULARE E INDUCONO IL DIFFERENZIAMENTO NEL CARCINOMA RENALE A CELLULE CHIARE. 147
DAAs rapidly reduce inflammation but increase serum VEGF level: A rationale for tumor risk during anti-HCV treatment 139
Analysis of the mutational status of the BRAF oncogene in familiar non-medullary thyroid carcinomas. 134
TRAP1 regulates cell cycle and apoptosis in thyroid carcinoma cells 131
FUNCTIONAL CHARACTERIZATION OF TRAP1 PATHWAY IN MULTIDRUG RESISTANCE IN HUMAN COLORECTAL CARCINOMA 126
Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines 125
DAAs increase serum VEGF level: a rationale for tumour risk recurrence during anti-HCV treatment 125
Ruolo del signaling dell’EGF nel fenotipo angiogenetico del carcinoma indifferenziato della tiroide: implicazioni terapeutiche 123
THE CALCIUM-BINDING PROTEIN S100A13 CORRELATES WITH AN ANGIOGENIC PHENOTYPE IN MALIGNANT MELANOMA 120
TRAP1 favor glycolytic metabolism and resistance to EGFR inhibitors in human colorectal carcinoma through regulation of PFK. 119
REVERSE TRANSCRIPTASE (RT) INHIBITORS INDUCE DIFFERENTIATION AND UPREGULATE MHC CLASS I IN HUMAN RENAL CLEAR CELL CARCINOMA. 118
COMPARATIVE GENE EXPRESSION PROFILING OF TOBACCO-ASSOCIATED HPV-POSITIVE VERSUS NEGATIVE ORAL SQUAMOUS CARCINOMA CELL LINES. 118
Gli inibitori della retrotrascrittasi inducono l'espressione di TPO e Tireoglobulina in colture primarie di carcinoma indifferenziato della tiroide 116
Erlotinib enhances the proapoptotic activity of cytotoxic agents and synergizes with paclitaxel in poorly-differentiated thyroid carcinoma cells. 116
Trap1, a novel antiapoptotic gene responsible for multidrug resi stance in human colorectal carcinoma cells. 115
TRAP1 controls cell cycle G2–M transition through the regulation of CDK1 and MAD2 expression/ubiquitination 110
TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells 109
BRAF V600E and KRAS G12R mutations correlate with Sunitinib resistance in thyroid cancer cell lines. 109
Il Sunitinib inibisce la proliferazione di linee di carcinoma tiroideo BRAF e KRAS wild-type. 108
Meccanismi molecolari coinvolti nell’azione differenziante della nevirapina nel carcinoma indifferenziato della tiroide. 107
PRECLINICAL EVIDENCES ON THE ACTIVITY OF EGFR1 INHIBITORS IN POORLY-DIFFERENTIATED THYROID CARCINOMA CELLS 106
TRAP1, a novel antiapoptotic gene responsible for multidrug resistance. 104
Gli inibitori della retrotrascrittasi inducono il differenziamento cellulare e ripristinano la captazione di iodio nel carcinoma anaplastico della tiroide sia in vitro che in vivo 104
RAS/BRAF mutational status in familial non-medullary thyroid carcinomas: A retrospective study 104
Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma 103
Trap-1, a novel antiapoptotic gene responsible for resistance to chemotherapeutic agents in human colorectal carcinoma. 100
TRAP1 controls cell cycle progression through the regulation of CDK1 and MAD2 expression/ubiquitination in human breast, colon and lung carcinomas. 100
TRAP1 controls cell cycle G2-M transition through the regulation of CDK1 and MAD2 expression/ubiquitination 100
S100A13 is a new angiogenic marker in human melanoma 99
Functional characterization of TRAP1 pathway in multidrug resistance in human colorectal carcinoma. 99
NOTCH SIGNALLING MODULATES HYPOXIA-INDUCED NEUROENDOCRINE DIFFERENTIATION OF HUMAN PROSTATE CANCER CELLS 99
Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy. 98
Nevirapine restores hormone sensitivity in undifferentiated androgen-refractory prostate carcinoma cells 97
Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells 97
TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas. 96
Sorcin induces a drug-resistant phenotype in human colorectal cancer through the modulation of Ca2+ homeostasis. 95
Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1 95
TRAP1 favors glycolytic metabolism and resistance to EGFR inhibitors in human colorectal carcinoma through regulation of PFK. 95
TRAP1 is a novel molecular target in BRAF-driven human colorectal carcinomas 95
TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas 94
The reciprocal regulation between TRAP1 and BRAF is responsible for control of cell cycle progression and modulation of mitochondrial apoptotic pathway. 93
REVERSE TRANSCRIPTASE INHIBITORS INDUCE CELL DIFFERENTIATION AND ENHANCE THE IMMUNOGENIC PHENOTYPE IN HUMAN RENAL CELL CARCINOMA 90
ER stress protection by TRAP1 induces resistance to paclitaxel in breast carcinoma cells 90
Reverse transcriptase inhibitors down-regulate cell proliferation in vitro and in vivo and restore thyrotropin signaling and iodine uptake in human thyroid anaplastic carcinoma 89
Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma 88
Mitochondrial chaperone Trap1 and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agents. 87
The inhibition of EGF signaling as a new molecular-targeted therapy in poorly differentiated thyroid carcinoma: preclinical evidences 87
TRAP1 and the calcium binding protein sorcin interact in mitochondria and protect cells against apoptosis induced by antiblastic agents. 87
The Role of Survivin in Thyroid Tumors: Differences of Expression in Well-Differentiated, Non–Well-Differentiated, and Anaplastic Thyroid Cancers 87
PRECLINICAL EVIDENCE OF THE ROLE OF EGF SIGNALING IN POORLY-DIFFERENTIATED THYROID CARCINOMA: A NEW MOLECULAR TARGET FOR THERAPY? 86
TRAP1 and the proteasome regulatory particle TBP7/Rpt3 interact in the endoplasmic reticulum and control cellular ubiquitination of specific mitochondrial proteins. 86
Epidermal growth factor receptor 1 expression is upregulated in undifferentiated thyroid carcinomas in humans. 86
Obstructive Sleep Apnea Worsens Progression-Free and Overall Survival in Human Metastatic Colorectal Carcinoma 86
The role of EGF signaling in the progression toward a poorly-differentiated mesenchymal-like phenotype in thyroid carcinoma cells 84
The role of RT inhibitors as a novel molecular targeted treatment in the management of anaplastic thyroid cancer. 84
Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo. 83
TRAP1 and sorcin cooperate in a survival pathway responsible for inducing drug-resistance in human colorectal carcinoma. 82
FATTORI CORRELATI CON LA TOSSICITA’ DELLA NEVIRAPINA IN PAZIENTI AFFETTI DA CARCINOMA INDIFFERENZIATO DELLA TIROIDE. 82
Differential and divergent activity of insulin-like growth factor binding protein 6 in platinum-sensitive versus platinum-resistant high-grade serous ovarian carcinoma cell lines 80
TRAP1, A NOVEL ANTIAPOPTOTIC MARKER OF RESISTANCE TO ANTIBLASTIC AGENTS IN HUMAN COLORECTAL CANCER 80
Nevirapine toxicity in non-HIV cancer patients 80
Comparative gene expression profiling of tobacco-associated HPV-positive versus negative oral squamous carcinoma cell lines 80
IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment-Current State and Future Perspectives 78
TRAP1 and Sorcin cooperate in inducing a multidrug resistance phenotype in human colorectal carcinoma. 77
Reverse transcriptase (RT) inhibitors: a new molecular-targeted differentiating therapy for undifferentiated thyroid tumors? 76
Evidence‐based second‐line treatment in ras wild‐type/mutated metastatic colorectal cancer in the precision medicine era 76
The role of EGF signaling in the poorly-differentiated phenotype of thyroid carcinoma cells: a new molecular target for therapy? 75
KRAS and BRAF mutational status predicts the sensitivity of thyroid carcinoma cell lines to sunitinib. 75
Reverse Transcriptase Inhibitors Induce An Androgen-Dependent Phenotype In Undifferentiated Androgen-Independent Prostate Carcinoma Cells. 74
PRELIMINARY ANALYSIS OF THE GENE EXPRESSION PROFILE OF JAGGED/NOTCH SIGNALING PATHWAY COMPONENTS IN HUMAN THYROID CARCINOMAS 74
TRAP1 and sorcin cooperate in a survival pathway responsible for inducing drug-resistance in human colorectal carcinoma (CRC) 71
Targeting epidermal growth factor receptor 1 signaling in human thyroid-stimulating hormone-independent thyroid carcinoma FRO cells results in a more chemosensitive and less angiogenic phenotype 71
THE ROLE OF SURVIVIN IN THYROID TUMORS: DIFFERENCES OF EXPRESSION IN WELL DIFFERENTIATED (WDTC), NON-WELL DIFFERENTIATED (NON-WDTC) AND ANAPLASTIC (ATC) THYROID CANCERS. 71
REVERSE TRANSCRIPTASE (RT) INHIBITORS AS DIFFERENTIATING DRUGS FOR THERAPY OF UNDIFFERENTIATED THYROID TUMOURS. 70
Pancreatic Enzyme Replacement and Nutritional Support With nab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic Cancer 69
TRAP1 induces a multi-drug resistant phenotype in BRAF V600E colorectal carcinoma cells by reducing the activation of mitochondrial ERK and favoring resistance to apoptosis. 69
TRAP1 is involved in BRAF regulation and downstream attenuation of ERK phosphorylation and cell-cycle progression: a novel target for BRAF-mutated colorectal tumors. 67
THE EGFR1 SIGNALING IN POORLY-DIFFERENTIATED THYROID CARCINOMA: A NEW TARGET FOR THERAPY? 65
IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment-Current State and Future Perspectives 64
TRAP1 regulates the response of colorectal cancer cells to hypoxia and inhibits ribosome biogenesis under conditions of oxygen deprivation 63
Mechanism of action and therapeutic targeting of mTOR pathway. 62
TRAP1 is responsible for the co-translational regulation of BRAF and the downstream attenuation of ERK phosphorylation and cell cycle progression: A novel molecular target for human BRAF-mutated colorectal carcinomas 61
Novel strategies to improve the efficacy of anticancer agents in human colorectal carcinoma. 59
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis 58
Cellular and Molecular Mechanisms Modulated by Genistein in Cancer. 38
TRAP1 modulates mitochondrial biogenesis via PGC-1α/TFAM signalling pathway in colorectal cancer cells 36
Nevirapine Restores Androgen Signaling in Hormone-Refractory Human Prostate Carcinoma Cells Both In Vitro and In Vivo (vol 69, pg 744, 2009) 18
The Multifaceted Role of Mitochondria in Angiogenesis 6
From Metabolic to Epigenetic Memory: The Impact of Hyperglycemia-Induced Epigenetic Signature on Kidney Disease Progression and Complications 5
Totale 7.900
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.112
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.112
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021330 0 0 0 0 0 41 87 22 93 83 1 3
2021/2022401 70 6 8 6 28 12 17 31 45 25 27 126
2022/20231.931 145 77 109 91 143 177 16 150 905 12 42 64
2023/2024444 76 14 29 16 32 172 15 31 2 10 1 46
2024/20251.247 55 45 24 55 62 155 134 71 291 64 141 150
2025/20261.091 155 216 234 254 143 89 0 0 0 0 0 0
Totale 7.900